Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "No classical pharmacological target" refers to a classification for therapeutic agents that do not exert their effects by binding to specific biological macromolecules such as receptors, enzymes, or ion channels. Instead, these substances typically function through direct physicochemical interactions within the body, such as chemical neutralization, osmotic pressure alteration, or physical adsorption (StatPearls, 2023). Common examples include antacids like aluminum hydroxide, which neutralize gastric acid through a simple acid-base reaction, and osmotic laxatives like magnesium sulfate that draw water into the intestinal lumen (NCBI, 2022). Chelating agents also fall into this category as they work by chemically sequestering metal ions rather than interacting with a protein binding site (Britannica, 2024). Because these agents lack a specific molecular target, they do not adhere to traditional pharmacological principles like the lock-and-key model or structure-activity relationships. This classification is vital for drug databases and regulatory bodies to distinguish between targeted molecular therapies and those with broad, non-specific mechanisms of action (ChEMBL, 2024). While effective, these agents can present unique safety challenges, such as systemic electrolyte imbalances or interference with the absorption of other medications.
Physicochemical interaction including chemical neutralization, osmotic gradient creation, physical adsorption, and surface tension modification.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No classical pharmacological target.